Clinical Trial: A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)

U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07812597) titled 'A Study Evaluating Safety and Tolerability of Switching From Semaglutide to Zovaglutide in Adults With Obesity (HORIZON-SWITCH-SZ)' on Aug. 31.

Brief Summary: The main purpose of this study is to evaluate the safety and tolerability of continuing treatment with zovaglutide injection following titration to 2.4 mg semaglutide injection in adult participants with obesity.

Study Start Date: Oct. 12

Study Type: INTERVENTIONAL

Condition: Obesity

Intervention: DRUG: zovaglutide Arm 1

Zovaglutide will be administered via subcutaneous (SC) injection.

DRUG: zovaglutide Arm 2

Zovaglutide will be administered via subcutaneous (SC) inj...